Snelgrove Paul V R
Department of Ocean Sciences and Biology Department, Memorial University of Newfoundland, St. John's NL, Canada.
Planta Med. 2016 Jun;82(9-10):790-9. doi: 10.1055/s-0042-103934. Epub 2016 Apr 19.
The 70 % of Earth's surface covered by oceans supports significant biological diversity and immense untapped potential for marine bioproducts. The recently completed international Census of Marine Life (2000-2010) invested heavily in evaluating the diversity, abundance, and distribution of life in the ocean but concluded that at least 50 % and potentially > 90 % of marine species remain undescribed by science. Despite this potential, and numerous successes spanning pharmaceuticals, nutraceuticals, anti-foulants and adhesives, biofuels, biocatalysts (enzymes), and cosmetics, several impediments have slowed marine bioproduct development. First, the sheer size of the ocean constrains comprehensive exploration. Second, marine taxonomists and ecologists generally do not focus on the most promising groups for bioproduct development. Third, the geographic mismatch between (often remote) biodiversity hotspots and science capacity limit discovery. Despite these challenges, new ocean sampling tools (digital imaging, remote vehicles, genetic approaches, in situ samplers), many developed or improved during the Census of Marine Life, should enhance future marine biodiversity and thus marine bioproduct discovery.
地球表面70%被海洋覆盖,海洋拥有丰富的生物多样性以及尚未开发的巨大海洋生物制品潜力。最近完成的国际海洋生物普查(2000 - 2010年)在评估海洋生物的多样性、丰度和分布方面投入巨大,但得出结论认为,至少50%以及可能超过90%的海洋物种尚未被科学描述。尽管有这种潜力,并且在制药、营养保健品、防污剂和粘合剂、生物燃料、生物催化剂(酶)以及化妆品等领域取得了诸多成功,但仍有几个障碍减缓了海洋生物制品的开发。首先,海洋的巨大规模限制了全面探索。其次,海洋分类学家和生态学家通常不关注生物制品开发最有前景的类群。第三,(通常偏远的)生物多样性热点地区与科研能力之间的地理不匹配限制了发现。尽管存在这些挑战,但在海洋生物普查期间开发或改进的许多新的海洋采样工具(数字成像、遥控潜水器、基因方法、原位采样器)应能提升未来的海洋生物多样性,从而促进海洋生物制品的发现。